Terns Pharmaceuticals, Inc. — Form D

Terns Pharmaceuticals, Inc. of FOSTER CITY, CA, a company, filed a Form D exempt-offering notice with the SEC on 2021-01-07. The offering totals $97.7M, of which $97.7M was reported sold. Industry: Pharmaceuticals.

Offering

Filed: 2021-01-07
Form: D
Accession: 0001567619-21-000704
Industry: Pharmaceuticals
Exemptions: 06b
Total offering: $97.7M
Amount sold: $97.7M
Investors: 13
Date of first sale: 2020-12-29
Security types: equity
Revenue range: Decline to Disclose
SEC file number: 021-385533

Issuer

Name: Terns Pharmaceuticals, Inc.
CIK: 0001831363
Entity type: Corporation
Jurisdiction: DELAWARE
Incorporated: 2020
Address: 1065 EAST HILLSDALE BLVD., SUITE 100, FOSTER CITY, CA, 94404
Phone: 650-525-5535 EXT.101

Officers, directors & promoters (13)

Name	Role	Location
David Fellows	Director	STEVENAGE, HERTFORDSHIRE, X0
Carl Gordon, Ph.D.	Director	SOUTH SAN FRANCISCO, CA
Jeffrey Kindler	Director	Foster City, CA
Hongbo Lu, Ph.D.	Director	Foster City, CA
Jill Quigley	Director	Foster City, CA
Yi Shi, Ph.D.	Director	Foster City, CA
Senthil Sundaram	Director	Chicago, IL
Elise Wang	Director	Foster City, CA
Weidong Zhong, Ph.D.	Director	Foster City, CA
Senthil Sundaram	Executive Officer	Chicago, IL
Mark Vignola, Ph.D.	Executive Officer	Foster City, CA
Bryan Yoon	Executive Officer	Foster City, CA
Weidong Zhong, Ph.D.	Executive Officer	Foster City, CA

More